Hello and Welcome to Patientsville.com, Your Source for all ALPHAGAN information. We are dedicated to provide You with ALPHAGAN safety information. Learn about ALPHAGAN serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ALPHAGAN Safety Reports
Total ALPHAGAN reports: 26.ALPHAGAN FDA safety alerts: No.
Reported deaths: 1 Reported hospitalizations: 13.
Take ALPHAGAN Side Effects Survey or Share Your ALPHAGAN Story. Read More Here.
Consumer or non-health professional from reported ALPHAGAN problem on Jan 10, 2007. Male patient was diagnosed with prophylaxis and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: apnoea, lethargy, respiratory rate decreased. ALPHAGAN dosage: unknown. Patient was hospitalized. Patient recovered.
ALPHAGAN problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2007. Male patient was diagnosed with intraocular pressure increased and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: apnoeic attack, lethargy. ALPHAGAN dosage: unknown. During the same period patient was treated with ECHOTHIOPHATE IODIDE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from CANADA reported ALPHAGAN problem on Jan 25, 2007. Male patient, weighting 33.07 lb, was diagnosed with accidental exposure and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: accidental exposure, depressed level of consciousness, respiratory arrest. ALPHAGAN dosage: unknown. Patient was hospitalized. Patient recovered.
ALPHAGAN problem was reported by a Physician from UNITED STATES on Jan 30, 2007. Female patient, 85 years of age, was diagnosed with glaucoma and was treated with ALPHAGAN. ALPHAGAN dosage: unknown. During the same period patient was treated with LUMIGAN. Patient died on 01/23/2007.
Consumer or non-health professional from UNITED KINGDOM reported ALPHAGAN problem on Apr 17, 2007. Male patient, 76 years of age, was diagnosed with open angle glaucoma and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: ectropion. ALPHAGAN dosage: unknown. During the same period patient was treated with TRUSOPT, XALATAN. Patient was hospitalized. Patient recovered.
ALPHAGAN problem was reported by a Physician from UNITED STATES on Apr 26, 2007. Male patient, 86 years of age, weighting 150.6 lb, was diagnosed with glaucoma and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: corneal scar, eye irritation, ocular hyperaemia, pupillary reflex impaired, visual field defect. ALPHAGAN dosage: unknown. During the same period patient was treated with COSOPT, TRAVATAN, ASPIRIN, TERAZOSIN, SIMVASTATIN, LEVALBUTEROL TART, IPRATROPIUM BR. Patient recovered.
Physician from UNITED STATES reported ALPHAGAN problem on May 04, 2007. Male patient was diagnosed with glaucoma and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: renal failure acute. ALPHAGAN dosage: unknown. During the same period patient was treated with COUMADIN, GLUCOTROL, LISINOPRIL, LANTUS, BUMEX, ADVAIR DISKUS. Patient recovered.
ALPHAGAN problem was reported by a Physician from UNITED KINGDOM on May 21, 2007. Male patient was diagnosed with open angle glaucoma and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: conjunctival disorder, conjunctival hyperaemia, conjunctival oedema, ectropion, erythema, periorbital oedema, skin exfoliation. ALPHAGAN dosage: unknown. During the same period patient was treated with TIMOLOL MALEATE, TRUSOPT, XALATAN. Patient was hospitalized. Patient recovered.
Physician from UNITED KINGDOM reported ALPHAGAN problem on May 21, 2007. Male patient was diagnosed with open angle glaucoma and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: conjunctival disorder, conjunctival hyperaemia, conjunctival oedema, ectropion, erythema, periorbital oedema, skin exfoliation. ALPHAGAN dosage: unknown. During the same period patient was treated with DORZOLAMIDE, LATANOPROST. Patient recovered.
ALPHAGAN problem was reported by a Consumer or non-health professional from UNITED STATES on May 30, 2007. Female patient, 42 years of age, weighting 150.0 lb, was diagnosed with glaucoma, ocular hypertension and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: eye infection. ALPHAGAN dosage: unknown. Patient recovered.
Physician from UNITED STATES reported ALPHAGAN problem on May 21, 2007. Male patient, weighting 215.0 lb, was diagnosed with glaucoma and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased. ALPHAGAN dosage: unknown. During the same period patient was treated with COUMADIN, GLUCOTROL, LISINOPRIL, LANTUS, BUMEX, ADVAIR DISKUS. Patient recovered.
ALPHAGAN problem was reported by a Consumer or non-health professional from UNITED STATES on June 12, 2007. Female patient, weighting 125.0 lb, was diagnosed with intraocular pressure increased and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: feeling abnormal, hypertension, palpitations, sensation of pressure, tinnitus. ALPHAGAN dosage: unknown. Patient recovered.
Physician from UNITED STATES reported ALPHAGAN problem on June 20, 2007. Female patient, 54 years of age, weighting 215.0 lb, was diagnosed with open angle glaucoma and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: intestinal obstruction. ALPHAGAN dosage: unknown. During the same period patient was treated with IBUPROFEN, TRAMADOL, VITAMIN A, LOVASTATIN, ESTER C, SOY SUPPLEMENT, LOTREL. Patient was hospitalized. Patient recovered.
ALPHAGAN problem was reported by a Consumer or non-health professional from UNITED STATES on July 06, 2006. Female patient, 94 years of age, was diagnosed with glaucoma and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, confusional state, dehydration, dizziness, dry mouth, eye disorder, eye irritation, haematocrit increased, photophobia. ALPHAGAN dosage: unknown. During the same period patient was treated with LASIX, ALPHAGAN P, COSOPT, LUMGAN, POTASSIUM. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ALPHAGAN problem on July 27, 2006. Female patient, 94 years of age, was diagnosed with glaucoma and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, confusional state, dehydration, dizziness, dry mouth, eye irritation, haematocrit increased, photophobia, red blood cell count increased. ALPHAGAN dosage: unknown. During the same period patient was treated with LASIX, ALPHAGAN P, COSOPT, LUMIGAN, POTASSIUM. Patient was hospitalized. Patient recovered.
ALPHAGAN problem was reported by a Consumer or non-health professional from UNITED STATES on July 27, 2006. Female patient, 94 years of age, was diagnosed with glaucoma and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, cataract operation, confusional state, dehydration, dizziness, dry mouth, eye irritation, haematocrit increased, photophobia. ALPHAGAN dosage: unknown. During the same period patient was treated with LASIX, COSOPT, LUMIGAN, POTASSIUM. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ALPHAGAN problem on Aug 08, 2006. Male patient, weighting 10.14 lb, was diagnosed with developmental glaucoma and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: apnoea, bradycardia, cyanosis, hypotension, respiratory depression, somnolence. ALPHAGAN dosage: unknown. During the same period patient was treated with VOLTAREN, CYCLOGYL. Patient recovered.
ALPHAGAN problem was reported by a Physician from UNITED STATES on June 14, 2006. Female patient was diagnosed with intraocular pressure increased and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: asthenia, dehydration, diarrhoea, gastrointestinal disorder, nausea, vomiting. ALPHAGAN dosage: unknown. During the same period patient was treated with LUMIGAN, COSOPT. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ALPHAGAN problem on Oct 10, 2006. Female patient, 84 years of age, was diagnosed with glaucoma and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, confusional state. ALPHAGAN dosage: unknown. During the same period patient was treated with TRUSOPT, XALATAN, AVAPRO, SYNTHROID. Patient recovered.
ALPHAGAN problem was reported by a Pharmacist from UNITED STATES on Oct 19, 2006. Male patient, 84 years of age, weighting 205.5 lb, was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: face oedema. ALPHAGAN dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE, EZOLANZAPINE, DILTIAZEM, VALSARTAN, BISACODYL, COLCHICINE, HYDRALAZINE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported ALPHAGAN problem on Nov 28, 2006. Male patient, 49 years of age, weighting 216.0 lb, was diagnosed with glaucoma and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: conjunctivitis. ALPHAGAN dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, ARTIFICIAL TEARS POLYVINYL ALCOHOL, ASPIRIN, ATENOLOL, CELLUVISC, CYCLOBENZAPRINE, FLUTICASONE PROP, GUAIFENESIN. Patient recovered.
ALPHAGAN problem was reported by a Physician from UNITED STATES on Oct 10, 2006. Female patient, weighting 161.0 lb, was diagnosed with glaucoma and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, cerebrovascular accident, confusional state, headache, refusal of treatment by patient. ALPHAGAN dosage: unknown. During the same period patient was treated with ALPHAGAN P, TRUSOPT, XALATAN, AVAPRO, SYNTHROID. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ALPHAGAN problem on Dec 13, 2006. Female patient, 78 years of age, weighting 140.0 lb, was diagnosed with glaucoma and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: suicidal ideation. ALPHAGAN dosage: unknown. Patient recovered.
ALPHAGAN problem was reported by a Physician from SWEDEN on Aug 02, 2007. Female patient was diagnosed with glaucoma and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: bradycardia, hyperglycaemia, hyperkalaemia, hypotension, vision blurred. ALPHAGAN dosage: unknown. During the same period patient was treated with COZAAR, COSOPT, WARAN, CARDIZEM. Patient was hospitalized. Patient recovered.
Physician from SWEDEN reported ALPHAGAN problem on Aug 02, 2007. Female patient was diagnosed with glaucoma and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: bradycardia, hyperglycaemia, hyperkalaemia, hypotension, vision blurred. ALPHAGAN dosage: unknown. During the same period patient was treated with COZAAR, COSOPT, WARAN, CARDIZEM. Patient was hospitalized. Patient recovered.
ALPHAGAN problem was reported by a Physician from SPAIN on Sept 03, 2007. Male patient was diagnosed with postoperative care and was treated with ALPHAGAN. After drug was administered, patient experienced the following problems/side effects: bradycardia, cyanosis, hypotonia. ALPHAGAN dosage: unknown. During the same period patient was treated with ESTILSONA, COLIRCUSI CICLOPLEJICO, TOBRADEX. Patient recovered.